Hedge Fund Database

OMEGA FUND MANAGEMENT, LLC

Adviser information for OMEGA FUND MANAGEMENT, LLC last updated from Form ADV on March 30th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.

Advisory Business

Type of Organization Limited Liability Company
Fiscal Year End DECEMBER
Legal Location Delaware, United States

Employees

Total Number of Employees 24
Investment Advisory/Research 12
Registered Broker-Dealer Representatives 0
Registered State Investment Advisers 0
Licensed Agents of an Insurance Company 0
No. of Firms/People that Solicit Clients 0

RAUM

Provides Management of Securities Portfolios Yes
Type Accounts RAUM
Discretionary 8 $1.6B
Non-Discretionary 0 $0
Total 8 $1.6B

Clients

Type Number RAUM
Individuals 0 $0
HNW Individuals 0 $0
Banking or thrift institutions 0 $0
Investment companies 0 $0
Business development companies 0 $0
Pooled investment vehicles 8 $1.6B
Pension and profit sharing plans 0 $0
Charitable organizations 0 $0
State or municipal gov entities 0 $0
Other investment advisers 0 $0
Insurance companies 0 $0
Sovereign wealth funds and foreign official institutions 0 $0
Corporations or other businesses 0 $0
Other 0 $0
Type Number
No. of Non-RAUM Clients 0
No. of Non-U.S. Clients 100

Services

Advisory Services Portfolio management for pooled investment vehicles
Compensation % of AUMPerformance-based fees

Identifiers

SEC RIA File Number 801-74224
SEC ERA File Number 801-74224
SEC CIK Numbers 1637359
SEC CRD Numbers 157753
Legal Entity Identifier None

Principal Office

888 BOYLSTON STREET
SUITE 1111
BOSTON
MA
United States
Monday - Friday, 9:00 AM TO 6:00 PM
Tel: 617-502-6530, Fax: None

Websites

omegafunds.com/ www.linkedin.com/company/omegafunds/

Chief Compliance Officer

MARK EMERSON RUSSELL JR.
VP, FINANCE
888 BOYLSTON STREET
SUITE 1111
BOSTON
MA
United States
Tel: 617-502-6540
(Full email address available in API data)

Regulatory Contact

ALEXANDRA RANKEL PEARSALL
CHIEF FINANCIAL OFFICER
888 BOYLSTON STREET
SUITE 1111
BOSTON
MA
United States
Tel: 617-921-2117
(Full email address available in API data)

Industry Affiliates

LS HOLDINGS SPV I G.P., LTD. Sponsor, GP, manager of pooled investment vehicles
LS HOLDINGS SPV I GP, L.P. Sponsor, GP, manager of pooled investment vehicles
OMEGA FUND II G.P., LTD. Sponsor, GP, manager of pooled investment vehicles
OMEGA FUND III G.P., LTD. Sponsor, GP, manager of pooled investment vehicles
OMEGA FUND III GP L.P. Sponsor, GP, manager of pooled investment vehicles
OMEGA FUND IV GP MANAGER, LTD. Sponsor, GP, manager of pooled investment vehicles
OMEGA FUND IV GP, L.P. Sponsor, GP, manager of pooled investment vehicles
OMEGA FUND V GP MANAGER, LTD. Sponsor, GP, manager of pooled investment vehicles
OMEGA FUND V GP, L.P. Sponsor, GP, manager of pooled investment vehicles
OMEGA FUND VI GP MANAGER, LTD. Sponsor, GP, manager of pooled investment vehicles
OMEGA FUND VI GP, L.P. Sponsor, GP, manager of pooled investment vehicles
OMEGA FUND VII GP MANAGER, LTD. Sponsor, GP, manager of pooled investment vehicles
OMEGA FUND VII GP, L.P. Sponsor, GP, manager of pooled investment vehicles
OMEGA FUND VIII GP MANAGER, LTD. Sponsor, GP, manager of pooled investment vehicles
OMEGA FUND VIII GP, L.P. Sponsor, GP, manager of pooled investment vehicles

Private Funds

Name Type Assets $USD Min Investment $USD No. Owners
LIFE SCIENCES HOLDINGS SPV I FUND, LP Private Equity Fund $0.2M $1.0M 1
NET ASSETS OF OMEGA FUND III, L.P. Private Equity Fund $3.1M $1.0M 15
OMEGA FUND II, LP Private Equity Fund $1.7M $1.4M 6
OMEGA FUND IV, L.P. Private Equity Fund $28.6M $1.0M 37
OMEGA FUND V, L.P. Private Equity Fund $67.8M $1.0M 34
OMEGA FUND VI, L.P. Private Equity Fund $268.5M $5.0M 45
OMEGA FUND VII, L.P. Private Equity Fund $323.8M $5.0M 87
OMEGA FUND VIII, L.P. Private Equity Fund $0.0M $1.0M 42

Control Persons

Name Type Entity Title Since Ownership
STAMPACCHIA, OTELLO, (NMN) Individual – MANAGER 04/2015 < 5%
RUSSELL, MARK, EMERSON Individual – CHIEF COMPLIANCE OFFICER 03/2016 < 5%
Nessi, Claudio, Pier Antonio Individual – MANAGER & MEMBER 11/2016 10-25%
CLESSIDRA, LLC Domestic Entity – MEMBER 04/2015 > 75%
STAMPACCHIA, OTELLO, (NMN) Individual CLESSIDRA, LLC MEMBER AND MANAGER 02/2015 > 75%
PEARSALL, ALEXANDRA, RANKEL Individual – CHIEF FINANCIAL OFFICER 07/2020 < 5%
DRAETTA, FRANCESCO, LUIGI Individual – MANAGER & MEMBER 10/2023 10-25%

No. Employees, Historic

30150201920202021202220232024202512 on 5/3/201912 on 11/22/201912 on 11/22/201915 on 3/30/202015 on 4/1/202015 on 8/10/202015 on 1/21/202119 on 3/31/202121 on 3/31/202223 on 3/31/202323 on 6/12/202324 on 3/30/2024

RAUM, Historic

2B1B020192020202120222023202420251043395124 on 5/3/20191043395124 on 11/22/20191043395124 on 11/22/20191169127664 on 3/30/20201169127664 on 4/1/20201169127664 on 8/10/20201169127664 on 1/21/20211296457582 on 3/31/20211911362032 on 3/31/20221394723335 on 3/31/20231394723335 on 6/12/20231592308964 on 3/30/2024

No. Clients, Historic

105020192020202120222023202420257 on 5/3/20197 on 11/22/20197 on 11/22/20197 on 3/30/20207 on 4/1/20207 on 8/10/20207 on 1/21/20217 on 3/31/20218 on 3/31/20227 on 3/31/20237 on 6/12/20238 on 3/30/2024

Holdings

From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name Class Value $USD # Shares Private Fund
Alumis Inc Common Stock 9M 653K –
enGene Holdings Inc. Common Stock 10M 1M –
enGene Holdings Inc. Warrant 383K 322K –
Ikena Oncology Common Stock 4M 2M –
Immunic Inc Common Stock 2M 2M –
Lexeo Therapeutics Common Stock 38M 2M –
Morphic Holding Common Stock 5M 160K –
Nuvation Bio Common Stock Class A 39M 13M –
Replimune Group Common Stock 22M 2M –
Sana Biotechnology, Inc. Common Stock 5M 844K –
Syros Pharmaceuticals Common Stock 1M 251K –